The U.S. stock market is experiencing a robust broad-based rally during midday trading this Tuesday, March 31st, 2026. Investors are shaking off recent volatility, evidenced by a significant retreat in the CBOE Volatility Index (VIX), which has plummeted nearly 9.5% to 27.71. This "risk-on" sentiment is being spearheaded by the technology sector, pushing the major indexes toward substantial daily gains as the first quarter of the year draws to a close.
Major Market Indexes Show Strong Midday Momentum
As of midday, the tech-heavy Nasdaq Composite (^IXIC) is the clear standout, surging 388.86 points, or 1.87%, to reach 21,183.50. This move reflects a renewed appetite for growth stocks and semiconductor leaders. The S&P 500 (^GSPC) is also seeing impressive gains, rising 89.23 points, or 1.41%, to sit at 6,432.95. Meanwhile, the Dow Jones Industrial Average (^DJI) has climbed 486.18 points, or 1.08%, currently trading at 45,702.32.
Small-cap stocks are not being left behind in this rally. The Russell 2000 (^RUT) is up 1.61%, signaling that the market breadth is healthy and not solely dependent on mega-cap tech. In the fixed-income market, the 30-Year Treasury Yield (^TYX) remains relatively flat at 4.906%, suggesting that the equity rally is being driven more by corporate optimism than by shifts in interest rate expectations.
Sector Highlights: Cannabis and Biotech Lead the Charge
From a sector perspective, the market is seeing explosive moves in speculative and growth-oriented areas. The Cannabis ETF (MSOS) is the day's top performer, gaining 7.14% amid renewed legislative optimism. Close behind is the Biotech sector, with the SPDR S&P Biotech ETF (XBI) rising 5.51%. Despite the general "risk-on" mood, precious metals are also showing strength; Gold Futures (GC=F) have jumped 1.90% to $4,643.90, and the Silver ETF (SLV) is up over 5%.
Conversely, defensive sectors are lagging. The Utilities Select Sector SPDR Fund (XLU) is the day's biggest laggard, dropping 0.87%, followed by Consumer Staples (XLP), which is down 0.66%. This rotation out of "safe-haven" sectors and into growth underscores the aggressive bullish tone of today's session.
Corporate News and Major Movers
The headline story in individual equities today is Apellis Pharmaceuticals (APLS), which has seen its stock price skyrocket by a staggering 136.4% in early and midday trading. This massive move follows positive clinical developments that have caught the attention of the entire healthcare sector. Similarly, Centessa Pharmaceuticals (CNTA) is enjoying a 45.2% gain.
In the premarket and early session, Classover Holdings (KIDZ) surged 76.6%, while on the downside, PepGen (PEPG) faced a sharp sell-off, losing 52.5% of its value.
Large-cap earnings are also dictating price action. Earlier today, McCormick & Company (MKC) and FactSet Research Systems (FDS) reported their quarterly results. McCormick is navigating a complex consumer environment, while FactSet continues to benefit from high demand for financial data. TD SYNNEX (SNX) also released its Q1 2026 results before the opening bell.
Upcoming Events to Watch
The market’s attention will shift significantly after the closing bell today when Nike (NKE) is scheduled to release its Q3 2026 earnings. Analysts are looking for an EPS of $0.29, and the results will be viewed as a critical barometer for global consumer discretionary spending. Other notable companies reporting after hours include PVH Corp (PVH) and RH (RH).
Looking ahead to tomorrow, Wednesday, April 1st, investors will receive updates from ConAgra Brands (CAG) and Cal-Maine Foods (CALM) before the market opens. These reports will provide further clarity on food inflation and the health of the American consumer as we head into the second quarter. With the S&P Futures (ES=F) currently up 1.30%, the stage is set for a potentially historic finish to the month if the current momentum holds through the afternoon session.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.